ChromaDex Raises FY2024 Sales Guidance from $91.93M-96.11M to $96.11M.
Portfolio Pulse from Benzinga Newsdesk
ChromaDex has increased its FY2024 sales guidance to $96.11 million, up from the previous range of $91.93 million to $96.11 million.
October 31, 2024 | 8:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ChromaDex has raised its FY2024 sales guidance to $96.11 million, suggesting improved revenue expectations.
The increase in sales guidance indicates that ChromaDex expects higher revenue, which is a positive signal for investors. This could lead to a short-term increase in stock price as the market reacts to the improved outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100